{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:08:48Z","timestamp":1785708528311,"version":"3.56.0"},"reference-count":80,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.1080\/17512433.2018.1497973","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T18:55:03Z","timestamp":1530903303000},"page":"689-703","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological resources, diagnostic approach and coordination of care in joint hypermobility-related disorders"],"prefix":"10.1080","volume":"11","author":[{"given":"Anwar","family":"Baban","sequence":"first","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Castori","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,7,19]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31539"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/msc.184"},{"key":"e_1_3_3_5_1","first-page":"804","article-title":"Epidemiology of general joint hypermobility and basis for the proposed criteria for benign joint hypermobility syndrome: review of the literature","volume":"34","author":"Remvig L","year":"2007","unstructured":"Remvig L, Jensen DV, Ward RC. Epidemiology of general joint hypermobility and basis for the proposed criteria for benign joint hypermobility syndrome: review of the literature. J Rheumatol. 2007;34:804\u2013809.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38106"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.32.5.413"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31540"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2003.tb10455.x"},{"key":"e_1_3_3_10_1","first-page":"535","article-title":"Articulaire consid\u00e9r\u00e9e comme facteur des alt\u00e9rations de l\u2019appareil locomoteur","volume":"7","author":"Rot\u00e9s J","year":"1957","unstructured":"Rot\u00e9s J, La Laxit\u00e9 AA. Articulaire consid\u00e9r\u00e9e comme facteur des alt\u00e9rations de l\u2019appareil locomoteur. Revue du Rhumatisme et maladies osteoarticulaires. 1957;7-8:535\u2013539.","journal-title":"Revue du Rhumatisme et maladies osteoarticulaires"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2214.2006.00694.x"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31460"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.26.5.419"},{"key":"e_1_3_3_14_1","first-page":"31","article-title":"Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997","volume":"77","author":"Beighton P","year":"1998","unstructured":"Beighton P, De Paepe A, Steinmann B, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998;77:31\u201337.","journal-title":"Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet"},{"key":"e_1_3_3_15_1","first-page":"1777","article-title":"The revised (Brighton 1998) criteria for the diagnosis of bening joint hypermobility syndrome (BJHS)","volume":"27","author":"Grahame R","year":"2000","unstructured":"Grahame R, Bird HA, Child A. The revised (Brighton 1998) criteria for the diagnosis of bening joint hypermobility syndrome (BJHS). J Rheumatol. 2000;27:1777\u20131779.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33070"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36805"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31552"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.072785"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.21037\/acs.2017.11.03"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31433"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/16501970510030156"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000541"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199609000-00012"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2015.03.002"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12087"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1386749"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70207-6"},{"key":"e_1_3_3_29_1","first-page":"998","article-title":"Symptom and joint mobility progression in the joint hypermobility syndrome (Ehlers-Danlos syndrome, hypermobility type)","volume":"29","author":"Castori M","year":"2011","unstructured":"Castori M, Sperduti I, Celletti C, et al. Symptom and joint mobility progression in the joint hypermobility syndrome (Ehlers-Danlos syndrome, hypermobility type). Clin Exp Rheumatol. 2011;29:998\u20131005.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31538"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31555"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33231"},{"issue":"107","key":"e_1_3_3_33_1","first-page":"116","article-title":"Hypermobility, the Ehlers-Danlos syndromes and chronic pain","volume":"35","author":"Syx D","year":"2017","unstructured":"Syx D, De Wandele I, Rombaut L, et al. Hypermobility, the Ehlers-Danlos syndromes and chronic pain. Clin Exp Rheumatol. 2017;35(Suppl 107):116\u2013122.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2012.12.051"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002847"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2011.02.006"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2499-0"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.856"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31554"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-009-0070-5"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36315"},{"key":"e_1_3_3_42_1","first-page":"1145","article-title":"Pain in Ehlers-Danlos syndromes: manifestations, therapeutic strategies and future perspectives","volume":"4","author":"Castori M","year":"2016","unstructured":"Castori M. Pain in Ehlers-Danlos syndromes: manifestations, therapeutic strategies and future perspectives. Expert Opin Drugs. 2016;4:1145\u20131158.","journal-title":"Expert Opin Drugs"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00728-X"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2011.04.003"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2014.08.010"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.02.013"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31532"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.5.1030"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2016.01.015"},{"key":"e_1_3_3_50_1","first-page":"183","article-title":"First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI","volume":"12","author":"Semler O","year":"2012","unstructured":"Semler O, Netzer C, Hoyer-Kuhn H, et al. First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI. J Musculoskelet Neuronal Interact. 2012;12:183\u2013188.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0145-1"},{"key":"e_1_3_3_52_1","first-page":"24","article-title":"Safety and efficacy of denosumab in children with osteogenesis imperfect\u2013a first prospective trial","volume":"16","author":"Hoyer-Kuhn H","year":"2016","unstructured":"Hoyer-Kuhn H, Franklin J, Allo G, et al. Safety and efficacy of denosumab in children with osteogenesis imperfect\u2013a first prospective trial. J Musculoskelet Neuronal Interact. 2016;16:24\u201332.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-013-9770-2"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71101"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31550"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.02.015"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2014.02.018"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx391"},{"key":"e_1_3_3_59_1","volume-title":"GeneReviews\u00ae [Internet]","author":"Loeys BL","year":"1993","unstructured":"Loeys BL, Dietz HC. Loeys-Dietz Syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al.editors. GeneReviews\u00ae [Internet]. Seattle (WA) Seattle:University of Washington; 1993-2018. 2018 Mar 1"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.116.001485"},{"key":"e_1_3_3_61_1","volume-title":"GeneReviews\u00ae [Internet]","author":"Dietz H","year":"1993","unstructured":"Dietz H. Marfan Syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al.editors. GeneReviews\u00ae [Internet]. Seattle (WA) Seattle:University of Washington; 1993-2018. 2017 Oct 12"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951112001412"},{"issue":"11","key":"e_1_3_3_63_1","first-page":"CD011103","article-title":"Beta-blockers for preventing aortic dissection in Marfan syndrome","author":"Koo HK","year":"2017","unstructured":"Koo HK, Lawrence KA, Musini VM. Beta-blockers for preventing aortic dissection in Marfan syndrome. Cochrane Database Syst Rev. 2017;11:CD011103.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.08.012"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706585"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.11.005"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht334"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.06.019"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574887109666140908125158"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404731"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31553"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60960-9"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31543"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9161865"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2009.08.003"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36574"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-008-0475-y"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31542"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1159\/000343738"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2009.06.001"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1124287"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33585"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2018.1497973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:12:51Z","timestamp":1770905571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2018.1497973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,3]]}},"alternative-id":["10.1080\/17512433.2018.1497973"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2018.1497973","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-03-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}